V-Ensure Pharma Technologies
V-Ensure Pharma Technologies is a pharmaceutical company dedicated to scientific research, formulation development, analytical services, and manufacturing. They serve global markets with a focus on quality, innovation, and regulatory compliance. Their services include formulation R&D, API R&D, analytical services, and cGMP manufacturing, with a strong emphasis on pharmaceutical development and technology.
Industries
Nr. of Employees
small (1-50)
V-Ensure Pharma Technologies
A-63, TTC Industrial Estate, Khairane MIDC, Navi Mumbai, Maharashtra – 400 705, INDIA.
Products
Injectable dosage form development
Development of injectable systems including emulsion-based delivery, nano-emulsions, particle-engineered long-acting suspensions, lyophilized formulations and dual-chamber prefilled systems.
Solid oral dosage forms
Development and manufacture of solid oral products including immediate-release tablets and capsules, modified-release tablets and capsules, pellets and mini-tabs, and sachet granules.
Liquid oral formulations
Development of liquid oral products including solutions, suspensions and powders for oral suspension.
Injectable dosage form development
Development of injectable systems including emulsion-based delivery, nano-emulsions, particle-engineered long-acting suspensions, lyophilized formulations and dual-chamber prefilled systems.
Solid oral dosage forms
Development and manufacture of solid oral products including immediate-release tablets and capsules, modified-release tablets and capsules, pellets and mini-tabs, and sachet granules.
Liquid oral formulations
Development of liquid oral products including solutions, suspensions and powders for oral suspension.
Services
End-to-end formulation development for solid oral, liquid oral and injectable dosage forms including QbD approaches, non-infringing formulation strategies, dossier preparation and regulatory filing support.
API and intermediate development including patent landscaping, polymorph screening, non-infringing synthetic route development, DMF filing support, analytical development and technology transfer.
Analytical method development, method transfer, method validation, stability study support and batch-release testing using chromatographic, spectroscopic and imaging techniques.
GMP-compliant contract manufacturing for solid oral finished dosage forms with integrated packaging; facility and production equipment for granulation, compaction, coating, capsule filling and packaging.
End-to-end formulation development for solid oral, liquid oral and injectable dosage forms including QbD approaches, non-infringing formulation strategies, dossier preparation and regulatory filing support.
API and intermediate development including patent landscaping, polymorph screening, non-infringing synthetic route development, DMF filing support, analytical development and technology transfer.
Analytical method development, method transfer, method validation, stability study support and batch-release testing using chromatographic, spectroscopic and imaging techniques.
GMP-compliant contract manufacturing for solid oral finished dosage forms with integrated packaging; facility and production equipment for granulation, compaction, coating, capsule filling and packaging.
Expertise Areas
- Formulation development for oral and parenteral dosage forms
- Controlled-release and multiparticulate systems
- API process development and intermediates
- cGMP commercial manufacturing for solid oral products
Key Technologies
- Hot-melt extrusion
- OROS and modified-release platforms
- Multi-unit particulate systems
- Nano-emulsion formulation
News & Updates
A fully operational facility capable of handling major solid oral dosage forms with advanced equipment, serving markets in USA, Europe, Canada, Australia, and others.
Recognized as a trusted contract research and development partner, offering end-to-end dossier development, formulation, and IP strategies, with successful product delivery.
The analytical laboratory earned successful inspection by the US FDA in February 2020, demonstrating quality and compliance.
A fully operational facility capable of handling major solid oral dosage forms with advanced equipment, serving markets in USA, Europe, Canada, Australia, and others.
Recognized as a trusted contract research and development partner, offering end-to-end dossier development, formulation, and IP strategies, with successful product delivery.
The analytical laboratory earned successful inspection by the US FDA in February 2020, demonstrating quality and compliance.